In light of our finding that stage III gastric tumors express higher levels of TrkB mRNA, we next investigated through an immunohistochemistry (IHC) analysis whether the elevated protein levels of TrkB and BDNF would correlate with disease severity in patients with gastric cancer. This evidence concerns the gene NTRK2 and gastric cancer.